All In Biotech

Drug Trial Radar · NCT05545137

Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection

Pivmecillinam Hydrochloride Tablets Versus Fosfomycin Tromethamine Granules for Uncomplicated Urinary Tract Infection in Women -A Randomized, Double-blind, Double Simulation, Positive Drug Parallel-controlled, Multi Center Phase III Clinical Trial in China

Last checked: Nov 20, 2026Latest source record: Apr 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 299 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

299

Actual

Start

Sep 29, 2022

Primary completion

Feb 5, 2024

Study completion Feb 20, 2024

Sponsor

Lead sponsor
Benova (Tianjin) Innovative medicine Research Co., Ltd.Academic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 19, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

the purpose of this study is to evaluate the efficacy and safety of pivmecillinam hydrochloride tablets in the treatment of uncomplicated urinary tract infection in China

Conditions

  • Uncomplicated Urinary Tract Infection

Interventions

  • Pivmecillinam hydrochloride tabletsDrug

    400mg tablet

  • Fosfomycin Tromethamine GranulesDrug

    3g/pack

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in urinary tract infection symptom scoreTime frame: From Baseline to Day 12±2
  2. Urine white blood cell countTime frame: Day 12±2

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing hospital

    Beijing, Beijing Municipality, China

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • Guangxi Zhuang Autonomous Region People's Hospital

    Nanning, Guangxi, China

  • The second hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • Wuhan Central Hospital

    Wuhan, Hubei, China

  • Xiangya Humanity Rehabilitation hospital

    Changsha, Hunan, China

  • Loudi Central Hospital

    Loudi, Hunan, China

  • Yueyang people's Hospital

    Yueyang, Hunan, China

  • Jiangsu Provincial Hospital of Integrated Chinese and Western Medicine

    Nanjing, Jiangsu, China

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.